Palantir Technologies Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Palantir Technologies wird ein jährliches Gewinn- und Umsatzwachstum von 23.3% bzw. 18% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 18% betragen.
Wichtige Informationen
23.3%
Wachstumsrate der Gewinne
21.9%
EPS-Wachstumsrate
| Software Gewinnwachstum | 17.2% |
| Wachstumsrate der Einnahmen | 18.0% |
| Zukünftige Eigenkapitalrendite | 18.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 07 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Palantir: Rally Isn't Over Yet (Rating Upgrade)
Nov 18I'm Into Value, I Avoided The Dot-Com Bubble, But I Still Say 'Buy' For Palantir
Nov 11Super Expensive Palantir Drops Heavily Anticipated Q3 Earnings
Nov 04Palantir Q3 Preview: Path To $61 Is Possible
Oct 28Palantir Stock Is Crushing Its Peers In AI Revenue
Oct 22Palantir Q3 Preview: I Have Strong Expectations, But It's Time To Sell
Oct 16Palantir: Top Line Expands, Dilution Shrinks Shareholder Value
Oct 06After Leaping 29% Palantir Technologies Inc. (NYSE:PLTR) Shares Are Not Flying Under The Radar
Oct 04
Palantir: Seeing Beyond The Overvaluation Debate
Sep 29Why I'm Downgrading Palantir Despite Strong U.S. Commercial And Government Growth
Sep 23Palantir: 200 Times Earnings Is Too Much!
Sep 17Palantir Stock: The Hype Train Speeds Ahead, But I'm Not Hopping On
Sep 11Palantir's Partnership With Microsoft Might Sustain Sentiment
Sep 05Palantir: A 65% Upside Potential By 2027 (Regression Analysis)
Aug 26Palantir: Don't Follow It Off The Cliff, Overpriced Generative AI Story
Aug 19Palantir: The Most Expensive SaaS In The Market For A Reason (Rating Upgrade)
Aug 11Palantir Q4 Preview: Ontology Is The Secret Weapon
Aug 04Palantir Technologies Inc.'s (NYSE:PLTR) P/S Still Appears To Be Reasonable
Aug 02Palantir: The Price Makes No Sense
Jul 23Palantir Leads The Data Revolution But Is Priced For Perfection
Jul 16Palantir Stock Is Not Worth The Risk Anymore (Downgrade)
Jul 02Palantir: What Is Priced In, And What Is Not
Jun 23Palantir: Why I'm Buying More Shares
Jun 17Palantir Is Positioned For Continued Growth
Jun 10Palantir: Insider Sales And High Valuations Vs Strong Operational Performance
Jun 04Here's Why We Think Palantir Technologies Inc.'s (NYSE:PLTR) CEO Compensation Looks Fair
May 30Palantir Technologies: The Market Is Too Optimistic
May 23Palantir: Not As Expensive As It Looks
May 16Palantir Technologies: It's A Mistake To Buy The Plunge Lower
May 07Palantir: Still Tons Of Upside
May 01Returns At Palantir Technologies (NYSE:PLTR) Are On The Way Up
Apr 15Palantir's Path To $100
Apr 09Palantir: Solid Fundamentals But Too Much Hype
Apr 03Palantir: AI Tailwinds May Not Outweigh Fundamentals
Mar 18Palantir: Why Doing Things Their Way Is Paying Off?
Mar 09The Market Is Expecting A Lot, But Palantir May Exceed Those Expectations
Mar 01Palantir: I Believe Healthcare Is The Key For S&P 500 Inclusion
Feb 19Palantir Q4: Fulfilling Promises But I Am Downgrading The Stock
Feb 12Palantir Stock Pops On Unwarranted Optimism, Avoid
Feb 05Palantir: Still Misunderstood - Disproving Bear Arguments
Jan 29Palantir Technologies Inc.'s (NYSE:PLTR) Share Price Matching Investor Opinion
Jan 26Palantir Stock: This Dip Is A Gift
Jan 15Palantir: AI Overhype Warning
Jan 08Is There An Opportunity With Palantir Technologies Inc.'s (NYSE:PLTR) 35% Undervaluation?
Jan 05Palantir: Not A Clear Alpha Play Anymore
Dec 26Palantir Has The AI Edge
Dec 17Palantir: Insider Selling And My Acid Test
Dec 08Why It Is Difficult To Justify Palantir's Stock Price
Nov 28The Return Trends At Palantir Technologies (NYSE:PLTR) Look Promising
Nov 24Palantir's NHS Deal Is All About The Optics
Nov 21Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 4,198 | 869 | 1,546 | 1,690 | 11 |
| 12/31/2025 | 3,467 | 640 | 1,167 | 1,222 | 19 |
| 12/31/2024 | 2,792 | 530 | 979 | 1,019 | 19 |
| 9/30/2024 | 2,646 | 477 | 980 | 995 | N/A |
| 6/30/2024 | 2,479 | 405 | 696 | 708 | N/A |
| 3/31/2024 | 2,334 | 299 | 641 | 654 | N/A |
| 12/31/2023 | 2,225 | 210 | 697 | 712 | N/A |
| 9/30/2023 | 2,125 | 147 | 475 | 490 | N/A |
| 6/30/2023 | 2,045 | -48 | 375 | 403 | N/A |
| 3/31/2023 | 1,985 | -256 | 346 | 376 | N/A |
| 12/31/2022 | 1,906 | -374 | 184 | 224 | N/A |
| 9/30/2022 | 1,830 | -561 | 197 | 238 | N/A |
| 6/30/2022 | 1,744 | -539 | 260 | 292 | N/A |
| 3/31/2022 | 1,647 | -498 | 225 | 252 | N/A |
| 12/31/2021 | 1,542 | -520 | 321 | 334 | N/A |
| 9/30/2021 | 1,431 | -513 | 211 | 222 | N/A |
| 6/30/2021 | 1,328 | -1,264 | 62 | 69 | N/A |
| 3/31/2021 | 1,205 | -1,236 | 98 | 107 | N/A |
| 12/31/2020 | 1,093 | -1,166 | -309 | -297 | N/A |
| 9/30/2020 | 1,000 | -1,186 | 47 | 57 | N/A |
| 6/30/2020 | 901 | -472 | -63 | -51 | N/A |
| 3/31/2020 | 811 | -502 | -295 | -282 | N/A |
| 12/31/2019 | 743 | -588 | -178 | -165 | N/A |
| 12/31/2018 | 595 | -598 | -54 | -39 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PLTRDas prognostizierte Gewinnwachstum (23.3% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: PLTRDie Erträge des Unternehmens (23.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: PLTREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: PLTRDie Einnahmen des Unternehmens (18% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: PLTRDie Einnahmen des Unternehmens (18% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: PLTRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (18%).